The Brain Tumor Biotech Center is lead by
John Boockvar, MD, and Marc Symons, PhD.
John Boockvar, MD, is internationally known for his surgical expertise and for providing patients with safe, effective, and minimally invasive treatment for brain tumors. Dr. Boockvar is the principal investigator of nine clinical trials for the treatment of malignant brain tumors and he currently holds four INDS from the FDA for the novel delivery of chemotherapy to patients with malignant brain tumors. He has over 15 years of basic laboratory experience and his laboratory has been funded by the National Institutes of Health.
Phone: (212) 434-3900
Marc Symons, PhD, is internationally known for his work on the analysis of signal transduction mechanisms in glioblastoma and medulloblastoma cells. Prior to joining Feinstein, Dr. Symons spent 6 years as a Scientist at Onyx Pharmaceuticals. An expert in immunomodulatory drugs and in overcoming therapeutic resistance in glioblastoma, Dr. Symons is developing novel approaches to sensitize brain tumors to radiation therapy, while protecting surrounding brain tissue.
Phone: (516) 562-1193